Progestin effects on long-term growth, death, and Bcl-xL in breast cancer cells

Biochemical and Biophysical Research Communications

Volumn 277, Issue 3, 2000, Pages 650-654

  Moore, Michael R ^a   Conover, Julie L ^a   Franks, Kevin M ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bax; Bcl 2; Bcl xL; Breast cancer; Cell death; Growth; Progestins; T47D cells

Indexed keywords

ANTIESTROGEN; ANTIGESTAGEN; GESTAGEN; PROTEIN BCL 2; PROTEIN BCL X;

ARTICLE; BREAST CANCER; CANCER GROWTH; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; HORMONE ACTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0034597740     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3728     Document Type: Article

References (27)

1. Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture
2. Induction and extinction of mammary cancer. A striking effect of hydrocarbons permits analysis of mechanisms of causes and cure of breast cancer
3. Progestin effects on growth in the human breast cancer cell line T47D - Possible therapeutic implications
4. Effects of progestins, estrogens and antihormones on growth and lactate dehydrogenase in the human breast cancer cell line T47D
5. Reversal of the anti-tumor effects of tamoxifen by progesterone in the 7,12 dimethylbenzanthracene-induced rat mammary carcinoma model
6. Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor α, epidermal growth factor receptor, c-fos and c-myc genes
7. Biphasic regulation of breast cancer cell growth by progesterone: Role of the cyclin-dependent kinase inhibitors, p21 and p27Kip1
8. Convergence of progesterone and epidermal growth factor signaling in breast cancer
9. Hypothesis: Progesterone primes breast cancer cells for cross-talk with proliferative or anti-proliferative signals
10. Analysis of the structure, transcripts and protein products of bcl-2, the gene involved in human follicular lymphoma
11. Bcl-2 initiates a new category of oncogenes: Regulators of cell death
12. Bcl-2 and the regulation of programmed cell death
13. The protooncogene bcl-2 and its role in regulating apoptosis
14. Antagonism between estradiol and progestin on Bcl-2 expression in breast cancer cells
15. Effect of antiprogestins and tamoxifen on growth inhibition of MCF-7 human breast cancer cells in nude mice
16. Additive effect of mifepristone and tamoxifen on apoptotic pathways in MCF-7 human breast cancer cells
17. Growth stimulation of T47D human breast cancer cells by the anti-progestin RU486
18. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor
19. Estrogen and progestin effects in human carcinogenesis
20. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk
21. Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function
22. Progestin stimulation of thymidine kinase in the human breast cancer cell line T47D
23. A sequence in the 5' flanking region confers progestin responsiveness on the human c-myc gene
24. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
25. Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement
26. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
27. Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women